In summary, CBD can ameliorate pathological processes and reverse cognitive deficits in AD through interaction with various AD targets such as microglia, antioxidant and anti-inflammatory properties, mitochondrial dysfunction, tau protein aggregation and neuron hyperexcitability. This evidence concerns the gene MAPT and Alzheimer disease.